Critical congenital heart disease (CCHD) screening practices and plans to implement routine pulse oximetry screening among Massachusetts hospitals and birth centers
Methods: Surveys were mailed to all 47 maternity hospitals and two birth centers in the state. The survey included questions about the hospital's screening protocol; plans for implementation; and capacity for follow-up diagnosis, treatment, and referrals for positive screens.
Results: MDPH received responses from all hospitals and birth centers. Whereas the two birth centers did not routinely screen for CCHD, 11 of the 47 hospitals (23%) reported performing the screening at the time of the survey. Of the 36 hospitals that reported not performing the screening, 19 (40%) had plans to implement screening, and 12 (26%) were still considering the screening. Four (9%) had not considered screening, and one hospital had decided against implementation. A comparison of hospital protocols in use revealed wide variation, including in the timing of screens, oxygen saturation thresholds, and follow-up procedures.
Conclusion: Members present at the final work group meeting unanimously agreed that MDPH should provide a single set of hospital screening guidelines to facilitate a more coordinated approach to implementation.
Learning Areas:Public health or related laws, regulations, standards, or guidelines
Describe the potential role of birth defects surveillance programs in coordinating a statewide approach to a new screening recommendation on the Recommended Uniform Screening Panel (RUSP)
Keyword(s): Birth Defects, Screening
Qualified on the content I am responsible for because: I have more than 25 years of MCH experience. For the past four years, I have been a senior consultant to the Massachusetts Center for Birth Defects and Research. In this role, I advise on the implementation of surveillance regulations in maternity hospitals, have organized a CCHD screening advisory committee, and conducted a CCHD hospital survey. I also am currently the lead of provider reporting for a CHD surveillance project in Massachusetts.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.